13FPulse
BI

BIO BIO-RAD LABORATORIES-A

2026Q2 · CUSIP 090572207 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
391
Institutions that reported holding it to the SEC
Net increase in holders
+1
Last quarter 390 → now 391
How unusual is that
Below average
Stronger than only 41% of US stocks
What the filings say, in one paragraph

391 funds held BIO at the end of 2026Q2, up 1 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $2.6B(YoY +1.4%), the P/E is 47.4x, return on equity is 3.1%. BIO has had 14 buying rushes in its history, and the price moved +9.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=196 2013Q4: holders=193 2014Q1: holders=191 2014Q2: holders=198 2014Q3: holders=198 2014Q4: holders=213 2015Q1: holders=216 2015Q2: holders=223 2015Q3: holders=241 2015Q4: holders=236 2016Q1: holders=227 2016Q2: holders=231 2016Q3: holders=236 2016Q4: holders=260 2017Q1: holders=276 2017Q2: holders=275 2017Q3: holders=267 2017Q4: holders=299 2018Q1: holders=316 2018Q2: holders=325 2018Q3: holders=340 2018Q4: holders=324 2019Q1: holders=346 2019Q2: holders=329 2019Q3: holders=358 2019Q4: holders=387 2020Q1: holders=403 2020Q2: holders=467 2020Q3: holders=476 2020Q4: holders=489 2021Q1: holders=490 2021Q2: holders=506 2021Q3: holders=505 2021Q4: holders=535 2022Q1: holders=513 2022Q2: holders=497 2022Q3: holders=484 2022Q4: holders=474 2023Q1: holders=506 2023Q2: holders=468 2023Q3: holders=468 2023Q4: holders=483 2024Q1: holders=465 2024Q2: holders=440 2024Q3: holders=439 2024Q4: holders=459 2025Q1: holders=435 2025Q2: holders=383 2025Q3: holders=398 2025Q4: holders=400 2026Q1: holders=390 2026Q2: holders=391 -64 -32 +0 +32 +64 171367562 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 14 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2023Q1 Top 5% +1.4% -19.3%
2021Q4 Top 20% -17.8% -15.2%
2021Q2 Top 20% +0.0% -20.5%
2020Q2 Top 5% +17.7% +28.1%
2020Q1 Top 5% +8.6% +27.8%
2019Q4 Top 20% +15.6% +25.5%
2019Q3 Top 5% +14.2% +32.0%
2019Q1 Top 20% +10.4% +19.3%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
193
Change in large funds
+1
Total value they hold
$5.7B
Funds buying for the first time
63
Funds that sold out entirely
62
Price change that quarter
+37.9%
Funds holding puts (bearish)
1
Funds holding calls (bullish)
3

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
47.4
EPS (TTM)
$8.19
EPS YoY
-30.2%
Revenue (TTM)
$2.6B
Revenue YoY
+1.4%
Net margin
8.6%
ROE
3.1%
Debt ratio
30.0%
FCF (TTM)
$353M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 130.02 2021-12-31: EPS -52.54 2022-03-31: EPS -112.50 2022-06-30: EPS -31.05 2022-09-30: EPS -5.48 2022-12-31: EPS 27.78 2023-03-31: EPS 2.32 2023-06-30: EPS -39.59 2023-09-30: EPS 3.64 2023-12-31: EPS 12.14 2024-03-31: EPS 13.45 2024-06-30: EPS -76.26 2024-09-30: EPS 23.34 2024-12-31: EPS -25.57 2025-03-31: EPS 2.29 2025-06-30: EPS 11.67 2025-09-30: EPS -12.70 2025-12-31: EPS 26.59 2026-03-31: EPS -19.55 2026-06-30: EPS 13.85 0M 395M 790M $M -123.75 9.64 143.02 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
8 27 46 20252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-96M75M245M 20162017201820192020202120222023202420252026
Latest quarter $78M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.